Lymphoma Hub | Quarter Three 2019 Update

The Lymphoma Hub continues to disseminate the latest clinical updates in lymphoma and chronic lymphocytic leukemia (CLL).

Guided by an international Steering Committee of world experts in lymphoma and CLL, the Lymphoma Hub is a global online resource that provides vital information for treatment teams, including hematologists and oncologists. With an ever-expanding social media presence, the Lymphoma Hub engages with the global community on all major social media networks, providing a finger on the pulse of everyday, real-world clinical practice.

The Lymphoma Hub is designed to deliver upon an unmet need for targeted medical updates, to help treatment teams involved in lymphoma and CLL care make informed therapeutic decisions. Last quarter, the Lymphoma Hub introduced new monthly educational themes showcasing content relating to hot topics in lymphoma and CLL. Themes so far include; chemotherapy-free treatments for indolent non-Hodgkin lymphoma (NHL) and mantle cell lymphoma (MCL), CAR T-cell therapy in diffuse large B-cell lymphoma (DLBCL) and CLL and high-risk patients. These themes were infused with the latest clinical and translational insights gathered during the seventh annual meeting of the Society of Hematologic Oncology (SOHO) in Houston, US.

The Lymphoma Hub showcases unbiased and credible evidence-based literature, drug approvals, case studies, international congress coverage and expert opinions, delivered by Scientific Education Support (SES). SES love nothing more than building communities and networks to enhance the level of collective knowledge, using multichannel communications to disseminate medical advances.

The Lymphoma Hub would like to thank our Platinum supporter Celgene, Silver supporters AstraZeneca and Janssen Oncology, and Bronze supporters Roche and Nordic Nanovector for their continued support. This year, the Lymphoma Hub is proud to announce Gilead Sciences as new Silver supporter and Karyopharm, as a new Contributor to the Lymphoma Hub.

For further information on the Lymphoma Hub, please visit: For media enquiries, or to explore collaboration opportunities, please contact:

Press release distributed by Pressat on behalf of Scientific Education Support, on Wednesday 30 October, 2019. For more information subscribe and follow

Lymphoma CLL Cancer Hematology Medical & Pharmaceutical
Published By

Scientific Education Support
Visit Newsroom


* For more information regarding media usage, ownership and rights please contact Scientific Education Support.

Additional PR Formats

You just read:

Lymphoma Hub | Quarter Three 2019 Update